![]() |
Name |
7-demethyl-glucopiericidin A
|
Molecular Formula | C36H55NO14 | |
IUPAC Name* |
2,3-dimethoxy-5-methyl-6-[(2E,5E,7E,9R,10R,11E)-3,9,11-trimethyl-10-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxytrideca-2,5,7,11-tetraenyl]-1H-pyridin-4-one
|
|
SMILES |
C/C=C(\C)/[C@@H]([C@H](C)/C=C/C=C/C/C(=C/CC1=C(C(=O)C(=C(N1)OC)OC)C)/C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)O)O)O
|
|
InChI |
InChI=1S/C36H55NO14/c1-8-19(3)32(20(4)13-11-9-10-12-18(2)14-15-22-21(5)25(39)33(46-6)34(37-22)47-7)51-36-31(45)29(43)27(41)24(50-36)17-48-35-30(44)28(42)26(40)23(16-38)49-35/h8-11,13-14,20,23-24,26-32,35-36,38,40-45H,12,15-17H2,1-7H3,(H,37,39)/b10-9+,13-11+,18-14+,19-8+/t20-,23-,24-,26+,27-,28+,29+,30-,31-,32+,35+,36+/m1/s1
|
|
InChIKey |
PZMGFIZMGVGUAT-PESLJEEUSA-N
|
|
Synonyms |
7-demethyl-glucopiericidin A
|
|
CAS | NA | |
PubChem CID | 139589533 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 725.8 | ALogp: | 1.7 |
HBD: | 8 | HBA: | 15 |
Rotatable Bonds: | 16 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 226.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 51 | QED Weighted: | 0.087 |
Caco-2 Permeability: | -5.669 | MDCK Permeability: | 0.00005330 |
Pgp-inhibitor: | 0.009 | Pgp-substrate: | 0.999 |
Human Intestinal Absorption (HIA): | 0.846 | 20% Bioavailability (F20%): | 0.019 |
30% Bioavailability (F30%): | 0.957 |
Blood-Brain-Barrier Penetration (BBB): | 0.098 | Plasma Protein Binding (PPB): | 88.57% |
Volume Distribution (VD): | 0.576 | Fu: | 8.53% |
CYP1A2-inhibitor: | 0.01 | CYP1A2-substrate: | 0.122 |
CYP2C19-inhibitor: | 0.022 | CYP2C19-substrate: | 0.471 |
CYP2C9-inhibitor: | 0.003 | CYP2C9-substrate: | 0.127 |
CYP2D6-inhibitor: | 0.024 | CYP2D6-substrate: | 0.234 |
CYP3A4-inhibitor: | 0.047 | CYP3A4-substrate: | 0.129 |
Clearance (CL): | 0.824 | Half-life (T1/2): | 0.645 |
hERG Blockers: | 0.023 | Human Hepatotoxicity (H-HT): | 0.333 |
Drug-inuced Liver Injury (DILI): | 0.699 | AMES Toxicity: | 0.273 |
Rat Oral Acute Toxicity: | 0.006 | Maximum Recommended Daily Dose: | 0.011 |
Skin Sensitization: | 0.716 | Carcinogencity: | 0.01 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.017 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003820 | ![]() |
0.866 | D0TC7C | ![]() |
0.338 | ||
ENC004854 | ![]() |
0.695 | D0I9HF | ![]() |
0.326 | ||
ENC002660 | ![]() |
0.664 | D0A8RX | ![]() |
0.315 | ||
ENC004855 | ![]() |
0.462 | D0Y3MO | ![]() |
0.289 | ||
ENC001847 | ![]() |
0.425 | D0YV1Q | ![]() |
0.284 | ||
ENC002950 | ![]() |
0.328 | D0P2IT | ![]() |
0.276 | ||
ENC002949 | ![]() |
0.328 | D07QQD | ![]() |
0.264 | ||
ENC003397 | ![]() |
0.320 | D04MRG | ![]() |
0.260 | ||
ENC001546 | ![]() |
0.314 | D07BSE | ![]() |
0.256 | ||
ENC002269 | ![]() |
0.312 | D04NDM | ![]() |
0.255 |